Open Actively Recruiting

Assessing the predictive capability of circulating tumor DNA (ctDNA) as a screening tool for ovarian cancer

About

Brief Summary

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

Phase
N/A

Eligibility

Minimum Age
N/A
Maximum Age
N/A

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
20-001223
Category
Ovarian Cancer
Contact
Chinazo Enigwe
Location
  • UCLA Westwood